Cardiomyopathies are a group of diseases that affect the heart muscle, leading to impaired heart function and, in severe cases, heart failure. These conditions can be caused by genetic factors, infections, or long-term health conditions such as hypertension. Cardiomyopathies are categorized into several types, including dilated, hypertrophic, and restrictive, each with distinct causes and symptoms. Early diagnosis and management are critical for improving the prognosis, and treatments may include medications, lifestyle changes, and in some cases, surgical interventions like heart transplants. With ongoing advancements in cardiology, there are now more options than ever for managing cardiomyopathies and helping patients lead healthy lives.
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile